Results 311 to 320 of about 9,064,819 (381)

ABO Hemolytic Disease of the Newborn

American Journal of Clinical Pathology, 1979
The charts of newborn infants with positive direct Coombs' test were studied. Only cases in which the mother's blood was group O and the infant's group A or group B were studied. There was no difference between group A and group B infants in the frequency and severity of the hemolytic process caused by maternal antibodies.
Sau-Yee Ann Chan-Shu, Olga M. Blair
openaire   +3 more sources

Identification of red blood cell antibodies in maternal breast milk implicated in prolonged hemolytic disease of the fetus and newborn

Transfusion, 2019
Alloantibodies against more than 50 non‐ABO blood group antigens have been implicated in hemolytic disease of the fetus and newborn (HDFN) and are expected to wane within weeks after delivery.
Alexis Leonard, Lauren Hittson Boal, Philippe P. Pary, Y. Mo, C. Jacquot, N. Luban, D. Darbari, J. Webb   +7 more
semanticscholar   +1 more source

Diagnostic value of laboratory monitoring to predict severe hemolytic disease of the fetus and newborn in non‐D and non‐K‐alloimmunized pregnancies

Transfusion, 2019
Pregnant women are routinely screened for red blood cell (RBC) antibodies early in pregnancy. If RBC‐alloantibodies are detected, repeated laboratory testing is advised to timely identify pregnancies at high risk for severe hemolytic disease of the fetus
J. Koelewijn, Y. Slootweg, C. Folman, I. V. Van Kamp, D. Oepkes, M. de Haas   +5 more
semanticscholar   +1 more source

Severe ABO Hemolytic Disease of the Newborn Requiring Exchange Transfusion

Journal of pediatric hematology/oncology, 2019
ABO incompatibility (ABOi), the most common cause of hemolytic disease of the newborn (HDN), is nearly always mild and treatable with phototherapy. Reports of ABOi HDN requiring neonatal exchange transfusion are extremely rare since the inception of ...
R. Metcalf, J. Khan, J. Andrews, D. Mayock, Zeenia C. Billimoria, M. Pagano   +5 more
semanticscholar   +1 more source

Acquired Hemolytic Disease

Postgraduate Medicine, 1966
Acquired hemolytic disease (AHD) is an auto-immune disease characterized primarily by a shortened life-span and rapid regeneration of red cells. Idiopathic or secondary AHD is suspected any time a chronically anemic patient also has a chronically elevated reticulocyte count. It is diagnosed by demonstrating the immune mechanism by the antiglobulin test
openaire   +3 more sources

Persistent hemolytic disease of the fetus and newborn (HDFN) associated with passive acquisition of anti‐D in maternal breast milk

Transfusion, 2017
Anti‐D is a well‐documented, significant cause of hemolytic disease of the fetus and newborn (HDFN), but its presence in breast milk is not routinely described.
Marissa Li, J. Blaustein
semanticscholar   +1 more source

Haptoglobin and Hemolytic Disease

JAMA: The Journal of the American Medical Association, 1981
To the Editor.— The article by Marchand et al (1980;243:1909) provides too much hope for a resurrection of haptoglobin determinations as a reliable indicator of hemolytic diseases. First, the introduction of any new or renewed diagnostic measurement should be based on a reliable diagnosis.
openaire   +3 more sources

Hemolytic Anemia in Wilson's Disease

New England Journal of Medicine, 1967
JAUNDICE is a common presentation of Wilson's disease and may precede the neurologic features by many years.1 , 2 Infective hepatitis is often invoked as an explanation of the initial episode, and Wilson's disease is rarely considered at that time. Subsequently, neurologic symptoms may lead to a correct diagnosis when such features as jaundice and ...
Neil McIntyre, H. M. Clink, J. N. Cumings, A.J. Levi, Sheila Sherlock   +4 more
openaire   +3 more sources

Hemochromatosis and Hemolytic Disease

Archives of Internal Medicine, 1980
Many hypotheses, most of them wrong, deal with the duodenum and iron absorption. At present, we accept that the balance of iron between the organism and its environment is controlled not by excretion of inadvertent excess but by the intestine's intelligent restriction of the amount it absorbs from dietary sources.
openaire   +3 more sources

Complement Activation and Inhibition in Autoimmune Hemolytic Anemia: Focus on Cold Agglutinin Disease.

Seminars in hematology (Print), 2018
The classical complement pathway and, to some extent, the terminal pathway, are involved in the immune pathogenesis of autoimmune hemolytic anemia (AIHA).
S. Berentsen
semanticscholar   +1 more source